Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hanbin Li

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
BMC Cardiovascular Disorders|September 27, 2025
The additive effect of cardiopulmonary fitness and triglyceride-glucose index on the risk of metabolic syndromeMengyi Li, Shiqi Wang, Hanbin Li, et al.
Journal of Medical Internet Research|February 26, 2024
Virtual Reality-Based Training in Chronic Low Back Pain: Systematic Review and Meta-Analysis of Randomized Controlled TrialsRan Li, Yinghao Li, Youli Kong, et al.
Clinical Pharmacokinetics|March 28, 2019
Population-Pharmacokinetic Modeling of Tildrakizumab (MK-3222), an Anti-Interleukin-23-p19 Monoclonal Antibody, in Healthy Volunteers and Subjects with PsoriasisPetra Jauslin, Pooja Kulkarni, Hanbin Li, et al.
Oncotarget|September 2, 2015
RY-2f, an isoflavone analog, overcomes cisplatin resistance to inhibit ovarian tumorigenesis via targeting the PI3K/AKT/mTOR signaling pathwayMingming Liu, Zihao Qi, Bingzhi Liu, et al.
Cancer Chemotherapy and Pharmacology|March 26, 2021
Selinexor population pharmacokinetic and exposure-response analyses to support dose optimization in patients with diffuse large B-cell lymphomaHongmei Xu, Hanbin Li, Russ Wada, et al.
Diabetology & Metabolic Syndrome|January 17, 2025
Association between weight-adjusted-waist index and long-term prognostic outcomes in cardiovascular disease patients: results from the NHANES 1999-2018 studyHanbin Li, Wen Zhong, Hongxin Cheng, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 18, 2025
Toward a Quantitative Understanding of Aficamten Clinical Pharmacology: Population Pharmacokinetic ModelingDonghong Xu, Hanbin Li, Stephen B Heitner, et al.
Clinical Pharmacology and Therapeutics|September 23, 2024
Population Pharmacokinetics and Exposure-Response Analysis of a Fixed-Dose Combination of Ivermectin and Albendazole in Children, Adolescents, and AdultsJaime Algorta, Stella Kepha, Alejandro Krolewiecki, et al.
Mediators of Inflammation|September 2, 2025
The Association Between Neutrophil-to-Lymphocyte Ratio, Atherogenic Index of Plasma, and Cardiovascular Disease IncidenceHongxin Cheng, Wen Zhong, Hanbin Li, et al.
Journal of Cellular and Molecular Medicine|February 5, 2025
Unlocking the Potential of Extracellular Vesicles in Cardiovascular DiseaseHanbin Li, Lu Wang, Hongxin Cheng, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
BMC Cardiovascular Disorders|September 27, 2025
The additive effect of cardiopulmonary fitness and triglyceride-glucose index on the risk of metabolic syndromeMengyi Li, Shiqi Wang, Hanbin Li, et al.
Journal of Medical Internet Research|February 26, 2024
Virtual Reality-Based Training in Chronic Low Back Pain: Systematic Review and Meta-Analysis of Randomized Controlled TrialsRan Li, Yinghao Li, Youli Kong, et al.
Clinical Pharmacokinetics|March 28, 2019
Population-Pharmacokinetic Modeling of Tildrakizumab (MK-3222), an Anti-Interleukin-23-p19 Monoclonal Antibody, in Healthy Volunteers and Subjects with PsoriasisPetra Jauslin, Pooja Kulkarni, Hanbin Li, et al.
Oncotarget|September 2, 2015
RY-2f, an isoflavone analog, overcomes cisplatin resistance to inhibit ovarian tumorigenesis via targeting the PI3K/AKT/mTOR signaling pathwayMingming Liu, Zihao Qi, Bingzhi Liu, et al.
Cancer Chemotherapy and Pharmacology|March 26, 2021
Selinexor population pharmacokinetic and exposure-response analyses to support dose optimization in patients with diffuse large B-cell lymphomaHongmei Xu, Hanbin Li, Russ Wada, et al.
Diabetology & Metabolic Syndrome|January 17, 2025
Association between weight-adjusted-waist index and long-term prognostic outcomes in cardiovascular disease patients: results from the NHANES 1999-2018 studyHanbin Li, Wen Zhong, Hongxin Cheng, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 18, 2025
Toward a Quantitative Understanding of Aficamten Clinical Pharmacology: Population Pharmacokinetic ModelingDonghong Xu, Hanbin Li, Stephen B Heitner, et al.
Clinical Pharmacology and Therapeutics|September 23, 2024
Population Pharmacokinetics and Exposure-Response Analysis of a Fixed-Dose Combination of Ivermectin and Albendazole in Children, Adolescents, and AdultsJaime Algorta, Stella Kepha, Alejandro Krolewiecki, et al.
Mediators of Inflammation|September 2, 2025
The Association Between Neutrophil-to-Lymphocyte Ratio, Atherogenic Index of Plasma, and Cardiovascular Disease IncidenceHongxin Cheng, Wen Zhong, Hanbin Li, et al.
Journal of Cellular and Molecular Medicine|February 5, 2025
Unlocking the Potential of Extracellular Vesicles in Cardiovascular DiseaseHanbin Li, Lu Wang, Hongxin Cheng, et al.
Pageof 4